Fulgent Genetics (FLGT) Income from Continuing Operations (2016 - 2026)
Fulgent Genetics' Income from Continuing Operations history spans 12 years, with the latest figure at 25278000.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 112.01% to 25278000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 14331000.0, a 61.01% increase, with the full-year FY2025 number at 1006000.0, up 97.4% from a year prior.
- Income from Continuing Operations hit 25278000.0 in Q1 2026 for Fulgent Genetics, down from 36975000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for FLGT hit a ceiling of 153557000.0 in Q1 2022 and a floor of 25278000.0 in Q1 2026.
- Historically, Income from Continuing Operations has averaged 3569588.24 across 5 years, with a median of 11600000.0 in 2023.
- Biggest five-year swings in Income from Continuing Operations: plummeted 1100.74% in 2023 and later surged 3631.52% in 2025.
- Tracing FLGT's Income from Continuing Operations over 5 years: stood at 24076000.0 in 2022, then skyrocketed by 202.09% to 24580000.0 in 2023, then plummeted by 104.26% to 1047000.0 in 2024, then surged by 3631.52% to 36975000.0 in 2025, then tumbled by 168.37% to 25278000.0 in 2026.
- Business Quant data shows Income from Continuing Operations for FLGT at 25278000.0 in Q1 2026, 36975000.0 in Q4 2025, and 6809000.0 in Q3 2025.